Furthermore, treatment of HepG2 cells with miR-744-enriched exosomes inhibited proliferation and sorafenib resistance in HCC through targeting paired box gene 2 (PAX2) [127]. The gene discussed is PAX2; the disease is hepatocellular carcinoma.